A study looked at using a GnRH‑agonist drug (triptorelin) instead of the usual hCG shot to trigger ovulation in women doing IUI with oral fertility meds. The group that got triptorelin had a slightly higher pregnancy rate (16% vs 11%), but the difference wasn’t statistically solid, so we can’t say it’s definitely better yet.

Gonadotropin-releasing hormone (GnRH) agonist trigger mimics the natural surge more closely with both luteinizing hormone (LH) and follicle-stimulating hormone surge. The present study attempts to find whether this apparent physiological advantage translates into the better pregnancy rate. To compare the effect of GnRH agonist versus human chorionic gonadotropin (hCG) trigger on the clinical pregnancy rate (CPR) in infertile women undergoing intrauterine insemination (IUI) with oral ovulogens. Retrospective analysis at a tertiary care <i>in vitro</i> fertilization center. The records of 280 infertile women, who underwent IUI with oral ovulogens were analyzed. Women who received 0.2 mg triptorelin (GnRH agonist (GnRHa)) as trigger were categorised in Group A (<i>n</i> = 129) and those who received 10,000 IU urinary hCG in Group B (<i>n</i> = 151). The outcome in terms of CPR was studied. The quantitative variables were compared using the independent <i>t</i>-test/Mann-Whitney test. The qualitative variables were compared using the Chi-square test. <i>P</i> &lt; 0.05 was considered statistically significant. There was a trend toward better CPR in Group A (21/129 - 16.28%) than in Group B (16/151 - 10.60%), although the difference was not found to be statistically significant (<i>P</i> - 0.162). There was a trend toward better CPR with the use of GnRH agonist trigger in IUI cycles with oral ovulogens in comparison to hCG trigger, although the difference was not found to be statistically significant. Further randomized controlled trials are needed to confirm these findings.